Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | CASP1 | P29466 | 1/20 | 0.60 |
| ▸ | CASP7 | P55210 | 1/20 | 0.60 |
| ▸ | PIK3CD | O00329 | 11/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | CLK1 | P49759 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15875824 | 0.93 | L3MBTL1 (0.53) | L3MBTL1TSHRALOX15CASP1CASP7 | |
| SCHEMBL716170 | 0.88 | PIK3CD (0.58) | L3MBTL1TSHRALOX15CASP1CASP7 | |
| SCHEMBL713514 | 0.80 | PIK3CD (0.48) | L3MBTL1TSHRALOX15CASP1CASP7 | |
| SCHEMBL682075 | 0.77 | KDM4E (0.61) | L3MBTL1TSHRCASP1CASP7KDM4E | |
| SCHEMBL15864240 | 0.76 | PIK3CD (0.54) | L3MBTL1TSHRALOX15CASP1CASP7 | |
| SCHEMBL716728 | 0.75 | PIK3CD (0.57) | L3MBTL1TSHRALOX15CASP1CASP7 | |
| SCHEMBL845236 | 0.74 | ALOX15 (0.59) | L3MBTL1TSHRALOX15CASP1CASP7 | |
| SCHEMBL715736 | 0.74 | ALOX15 (0.59) | L3MBTL1TSHRALOX15CASP1CASP7 | |
| SCHEMBL717333 | 0.73 | DRD4 (0.59) | L3MBTL1PIK3CDKDM4EGAAALDH1A1 | |
| SCHEMBL15875825 | 0.73 | L3MBTL1 (0.54) | L3MBTL1TSHRALOX15CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120053167-A1 | Triazine Derivatives as Kinase Inhibitors | UCB PHARMA, S.A. (BE) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053167-A1 | Triazine Derivatives as Kinase Inhibitors | MAP3K15, PI4KA, MAP3K20 | L3MBTL1 2277/4885TSHR 931/4885ALOX15 1365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.